NASHVILLE, Tenn., April 22, 2011 /PRNewswire/ — Cumberland
Pharmaceuticals Inc. (Nasdaq:
CPIX) announced today that it will release first quarter 2011
financial results after the market closes on Wednesday, May 4,
2011. A conference call and live Internet webcast will be held on
Wednesday, May 4, 2011 at 5:00 p.m. Eastern Time to discuss the
To participate in the call, please dial 877-303-1298 (for U.S.
callers) or 253-237-1032 (for international callers). A rebroadcast
of the teleconference will be available for one week and can be
accessed by dialing 800-642-1687 (for U.S. callers) or 706-645-9291
(for international callers). The Conference ID for the rebroadcast
is 62581136. The live webcast and rebroadcast can be accessed via
Cumberland’s website at http://investor.shareholder.com/cpix/events.cfm.
Cumberland Pharmaceuticals Inc. is a specialty
pharmaceutical company focused on the acquisition, development and
commercialization of branded prescription products. The Company’s
primary target markets include hospital acute care and
gastroenterology. Cumberland’s marketed products include
Acetadote® (acetylcysteine) Injection for the treatment
of acetaminophen poisoning, Caldolor® (ibuprofen)
Injection, the first injectable treatment for pain and fever
approved in the United States, and Kristalose®
(lactulose) for Oral Solution, a prescription laxative.
Cumberland is dedicated to providing innovative products that
improve quality of care for patients. For more information on
Cumberland, please visit the Company’s website at www.cumberlandpharma.com.